Reactive vascular lesions treated using ethanolamine oleate sclerotherapy

Area of Science:

• Dermatology
• Vascular Lesion Treatment
• Sclerotherapy

Background:

• Ethanolamine oleate (EO) is infrequently used in dermatology.
• It is recognized for treating various vascular lesions, including esophageal varices and varicose veins.

Purpose of the Study:

• To assess the efficacy and safety of Ethanolamine oleate (EO) for treating reactive vascular lesions.
• Investigate EO as a potential treatment for conditions like pyogenic granulomas and venous lakes.

Main Methods:

• Patients with reactive vascular lesions were treated with EO as a sclerosing agent.
• Initial treatment involved a 1:1 dilution with normal saline, with subsequent treatments adjusted based on response.
• Treatment outcomes were categorized as complete remission (CR), moderate improvement (MI), or no change, and side effects were documented.

Main Results:

• The study included 21 patients with pyogenic granulomas (16) and venous lakes (5).
• Lesion diameters ranged from 0.3 to 1.0 cm, with an average of 1.6 EO injections per patient.
• A 95% complete remission rate (20 CR, 1 MI) was observed, with only two instances of transient pain reported.

Conclusions:

• Ethanolamine oleate (EO) demonstrates excellent efficacy as a sclerosing agent for reactive vascular lesions.
• EO presents a viable alternative therapeutic option for managing vascular lesions within dermatological practice.